This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Family Research Council: Plan B Ruling Disregards Serious Health Concerns

WASHINGTON, April 5, 2013 /PRNewswire-USNewswire/ -- Anna Higgins, J.D., director of the Center for Human Dignity at the Family Research Council, expressed serious concerns regarding a federal judge's order today that the "morning-after" pill be available to girls of all ages without a prescription.


U.S. District Judge Edward Korman in Brooklyn, New York ordered the U.S. Food and Drug Administration to make the potent drug available.

Higgins made the following statement regarding the judge's order:

"This ruling places the health of young girls at risk.  Making Plan B available for girls under the age of 17 without a prescription flies in the face of medical information and sound judgment.  I am very troubled that the court has not fully taken into account the concerns expressed by HHS Secretary Kathleen Sebelius and many public health advocates that there is not enough data on the health effects of Plan B on young girls.

"According to the new numbers released by the Centers for Disease Control, there were 19,700,000 new STIs reported in 2008 – the last year for which numbers are available. Based on the CDC's estimates, that brings the total number of STIs in the U.S. to just over 110 million. Most of the new cases crop up in young men and women aged 15-25. Making Plan B available over-the-counter for any age will put many of these young girls at further risk because it circumvents necessary medical screening for sexually active girls.

"There is a real danger that Plan B may be given to young girls, under coercion or without their consent. The involvement of parents and medical professionals act as a safeguard for these young girls.  However, today's ruling removes these commonsense protections," concluded Higgins.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,814.61 +24.42 0.15%
S&P 500 1,980.97 +1.05 0.05%
NASDAQ 4,743.9590 -4.4020 -0.09%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs